null
ChEBI ID: 25381
| Member | Definition | Role |
|---|---|---|
| azd 1152 | A dihydrogen phosphate prodrug of a pyrazoloquinazoline aurora kinase inhibitor AZD1152-hydroxyquinazoline pyrazol anilide(HQPA) and is converted rapidly to the active AZD1152-HQPA in plasma. | AZT-1152 |
| fty 720p | A primary amino compound that is fingolimod in which one on the hydroxy groups has been converted into its dihydrogen phosphate derivative. It is the active metabolite of fingolimod. | fingolimod phosphate |
| glycolaldehyde phosphate | A member of the class of aldehydes that is glycolaldehyde in which the hydroxy hydrogen has been replaced by a phospho group. | glycolaldehyde phosphate |
| indolepropanol phosphate | An monoalkyl phosphate compound having an O-3-(indol-3-yl)propyl substituent. | 3-(indol-3-yl)propyl phosphate |
| methylphosphate | A monoalkyl phosphate having methyl as the alkyl group. | methyl dihydrogen phosphate |
| monoethyl phosphate | A monoalkyl phosphate epitope having ethyl as the alkyl group. | ethyl dihydrogen phosphate |
| phosphomevalonic acid | 3-hydroxy-3-methyl-5-phosphonooxypentanoic acid | |
| triclofos | Triclofos |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 28 (16.57) | 18.7374 |
| 1990's | 25 (14.79) | 18.2507 |
| 2000's | 45 (26.63) | 29.6817 |
| 2010's | 47 (27.81) | 24.3611 |
| 2020's | 24 (14.20) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 11 (6.29%) | 5.53% |
| Reviews | 7 (4.00%) | 6.00% |
| Case Studies | 5 (2.86%) | 4.05% |
| Observational | 3 (1.71%) | 0.25% |
| Other | 149 (85.14%) | 84.16% |